# Single Dose Escalation Study of PF-05190457 in Healthy Volunteers

> **NCT01247896** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 26 (estimated)

## Conditions studied

- Diabetes Mellitus, Type II

## Interventions

- **DRUG:** PF-05190457
- **DRUG:** PF-05190457
- **DRUG:** PF-05190457
- **DRUG:** PF-05190457
- **DRUG:** PF-05190457
- **DRUG:** PF-05190457
- **DRUG:** PF-05190457
- **DRUG:** PF-05190457
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01247896
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 26 (ESTIMATED)
- **Last updated:** 2011-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01247896

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01247896, "Single Dose Escalation Study of PF-05190457 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01247896. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*